Skip to nav Skip to content

Moffitt at SOHO 2025

We are excited to participate in the Society of Hematologic Oncology (SOHO) Annual Meeting from September 3-6, 2025.

Moffitt Cancer Center is proud to join leading experts from around the globe at the 2025 Society of Hematology Oncology (SOHO) Annual Meeting this September 3-6. Our faculty will present the latest advances in the diagnosis, treatment, and research of hematologic malignancies—sharing insights that are shaping the future of patient care.

From evolving treatment landscapes to cutting-edge immunotherapies, Moffitt’s contributions will spotlight innovations across the spectrum of blood cancers, including:

  • Anemia & MDS/MPNs: Latest clinical updates

  • AML & CPX-351: Emerging treatment strategies

  • CAR-T in ALL: Integration and toxicity management

  • High-Risk AML & CML: Novel immune and mutation-based approaches

  • Case Insights: Practical, patient-focused applications

Our mission is to transform the treatment of blood cancers through research-driven, patient-centered care. At SOHO 2025, Moffitt’s experts will showcase the science, collaboration, and innovation driving that mission forward.

Visit our Booth #104 to meet team members and learn more about the impact Moffitt is making in cancer research, outcomes and advancements. 

Follow Moffitt to learn more about Moffitt’s research and breakthroughs: 
LinkedIn
X | MoffittNews
Email

Faculty Presentations

Press Contact

Kim Polacek

Kim Polacek, APR, CPRC

National Media Manager

813-456-3342

  • Tuesday, September 2, 2025

    2:00pm

    Dr. Rami Komrokji
    Dr. Rami Komrokji
    The Evolving Landscape of Anemia in MDS & MPNs: Clinical Updates and Best Practices
       

     

  • Wednesday, September 3, 2025

    7:00am

    Dr. Jeffrey Lancet
    Dr. Jeffrey Lancet
    Meet the Professor Session: Future Role of CPX-351 and CPX-351-Based Combinations
    Dr. Rami Komrokji
    Dr. Rami Komrokji
    Meet the Professor Session: Promising Studies in MDS in 2025

    Dr. Javier Pinilla-Ibarz
    Dr. Javier Pinilla-Ibarz
    Meet the Professor Session - Case: Why I Started This Patient on VenG

     8:00am

    Dr. Fred Locke
    Dr. Fred Locke
    Meet the Professor Session: Emerging Toxicities of CAR-T
       

    10:01am

    Dr. Bijal Shah
    Dr. Bijal Shah
    Level 3, General Assembly
    Oral: CAR T Cells in ALL: Early Integration in Newly Diagnosed High-Risk ALL and Optimization of Post CAR T-Cells Outcome in Relapsed-Refractory Disease
       

    5:39pm

    Dr. David Sallman
    Dr. David Sallman
    Oral - Novel Strategies in High-Risk AML- Focus on Immune-Based Strategies 
       

     

  • Friday, September 5, 2025

    6:45am

    Dr. Kendra Sweet
    Dr. Kendra Sweet
    Breakfast With The Expert - When Do You Do Mutation Testing in CML and How Do You Decide If It Is Meaningful
       

     

Want to learn more about Moffitt?

What information are you interested in?

What is your preferred method of communication?

Moffitt Resources